Abstract
ObjectiveTo evaluate and compare benefits and harms of three biological treatments with different modes of action versus active conventional treatment in patients with early rheumatoid arthritis.DesignInvestigator initiated, randomised, open label,...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have